When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
NTRA - Natera teams up with Elicio in pancreatic cancer study
Natera Inc.
Cell-free DNA testing services provider Natera (NTRA-0.2%) will collaborate with Cambridge, MA-based Elicio Therapeutics on a Phase 1/2 clinical trial evaluating the latter's therapeutic cancer vaccine candidate ELI-002 for the adjuvant treatment of patients with pancreatic ductal adenocarcinoma, the most common type of pancreatic cancer, who have undergone neoadjuvant chemo followed by pancreatectomy (removal of the pancreas).
More news on: Natera, Inc., Healthcare stocks news,